Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Antileukemic effects described for vesnarinone

Nov. 28, 1997

Isis antisense compound enters phase II

Nov. 28, 1997

Boehringer Ingelheim and Vion sign agreement for Promycin

Nov. 28, 1997

Immunex seeks FDA approval for generic paclitaxel injection

Nov. 28, 1997

AnorMED's AMD-473 enters phase I

Nov. 27, 1997

Stress proteins shown to activate CTL response to cancer cells

Nov. 27, 1997

Cephalon and TAP renew oncology collaboration

Nov. 27, 1997

Preclinical pharmacokinetics, antitumor activity and toxicity of CI-994

Nov. 26, 1997

Cardiotoxicity of SM-5887 and doxorubicin compared in rabbits

Nov. 26, 1997

Preliminary results reported for IL-2 gene therapy in GI cancer

Nov. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...